X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2019 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Biocon Ltd with Dr. Reddys - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

BIOCON vs DR. REDDYS LAB - Comparison Results

BIOCON     Change

Biocon is India's largest biotechnology company with presence in biopharmaceuticals, custom research and clinical research. It started as an enzymes manufacturer and later evolved into an integrated biopharmaceutical company. The company has two subs... More

DR. REDDYS LAB 
   Change

Dr. Reddy's is a leading pharmaceutical company in the country with presence across the value chain. While the global generics business accounted for 69% of total revenues in FY12, the PSAI business (Pharma Services and Active Ingredients - PSAI) con... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    BIOCON DR. REDDYS LAB BIOCON /
DR. REDDYS LAB
 
P/E (TTM) x 18.5 22.2 83.3% View Chart
P/BV x 2.9 3.4 86.3% View Chart
Dividend Yield % 0.4 0.8 50.9%  

Financials

 BIOCON    DR. REDDYS LAB
EQUITY SHARE DATA
    BIOCON
Mar-18
DR. REDDYS LAB
Mar-18
BIOCON /
DR. REDDYS LAB
5-Yr Chart
Click to enlarge
High Rs1,1882,788 42.6%   
Low Rs3051,902 16.0%   
Sales per share (Unadj.) Rs68.7860.8 8.0%  
Earnings per share (Unadj.) Rs7.657.1 13.2%  
Cash flow per share (Unadj.) Rs14.0122.0 11.5%  
Dividends per share (Unadj.) Rs1.0020.00 5.0%  
Dividend yield (eoy) %0.10.9 15.7%  
Book value per share (Unadj.) Rs86.3757.7 11.4%  
Shares outstanding (eoy) m600.00165.91 361.6%   
Bonus/Rights/Conversions ISESOP-  
Price / Sales ratio x10.92.7 398.7%   
Avg P/E ratio x98.941.1 240.6%  
P/CF ratio (eoy) x53.419.2 278.0%  
Price / Book Value ratio x8.63.1 279.4%  
Dividend payout %13.235.0 37.8%   
Avg Mkt Cap Rs m447,900389,034 115.1%   
No. of employees `0006.123.5 26.1%   
Total wages/salary Rs m9,31132,149 29.0%   
Avg. sales/employee Rs Th6,705.86,070.8 110.5%   
Avg. wages/employee Rs Th1,514.21,366.6 110.8%   
Avg. net profit/employee Rs Th736.9402.5 183.1%   
INCOME DATA
Net Sales Rs m41,234142,810 28.9%  
Other income Rs m2,0621,552 132.9%   
Total revenues Rs m43,296144,362 30.0%   
Gross profit Rs m8,29123,512 35.3%  
Depreciation Rs m3,85110,772 35.8%   
Interest Rs m615788 78.0%   
Profit before tax Rs m5,88713,504 43.6%   
Minority Interest Rs m2130-   
Prior Period Items Rs m0344 0.0%   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,5694,380 35.8%   
Profit after tax Rs m4,5319,468 47.9%  
Gross profit margin %20.116.5 122.1%  
Effective tax rate %26.732.4 82.2%   
Net profit margin %11.06.6 165.7%  
BALANCE SHEET DATA
Current assets Rs m41,486104,984 39.5%   
Current liabilities Rs m21,41368,938 31.1%   
Net working cap to sales %48.725.2 192.9%  
Current ratio x1.91.5 127.2%  
Inventory Days Days6474 86.0%  
Debtors Days Days94104 90.9%  
Net fixed assets Rs m50,661104,385 48.5%   
Share capital Rs m3,000830 361.4%   
"Free" reserves Rs m48,808124,886 39.1%   
Net worth Rs m51,808125,716 41.2%   
Long term debt Rs m17,89825,089 71.3%   
Total assets Rs m99,897225,443 44.3%  
Interest coverage x10.618.1 58.3%   
Debt to equity ratio x0.30.2 173.1%  
Sales to assets ratio x0.40.6 65.2%   
Return on assets %5.24.5 113.2%  
Return on equity %8.77.5 116.1%  
Return on capital %9.69.7 99.3%  
Exports to sales %00-   
Imports to sales %00-   
Exports (fob) Rs mNANA-   
Imports (cif) Rs mNANA-   
Fx inflow Rs m12,05872,623 16.6%   
Fx outflow Rs m7,34818,916 38.8%   
Net fx Rs m4,71053,707 8.8%   
CASH FLOW
From Operations Rs m6,62118,030 36.7%  
From Investments Rs m-6,840-14,883 46.0%  
From Financial Activity Rs m-2,397-4,440 54.0%  
Net Cashflow Rs m-2,612-1,236 211.3%  

Share Holding

Indian Promoters % 40.4 25.5 158.4%  
Foreign collaborators % 20.6 0.0 -  
Indian inst/Mut Fund % 8.4 5.4 155.6%  
FIIs % 10.7 35.3 30.3%  
ADR/GDR % 0.0 18.5 -  
Free float % 19.9 15.3 130.1%  
Shareholders   109,995 75,885 144.9%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare BIOCON With:   FRESENIUS KABI ONCO.  AJANTA PHARMA  UNICHEM LAB  ALEMBIC PHARMA  CADILA HEALTHCARE  

Compare BIOCON With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Higher; Indusind Bank and Tata Motors Top Gainers(09:30 am)

Asian share markets are higher today as Japanese and Hong Kong shares show gains. The Nikkei 225 is up 0.8% while the Hang Seng is up 1%.

Related Views on News

BIOCON Announces Quarterly Results (4QFY19); Net Profit Down 53.8% (Quarterly Result Update)

Apr 26, 2019 | Updated on Apr 26, 2019

For the quarter ended March 2019, BIOCON has posted a net profit of Rs 705 m (down 53.8% YoY). Sales on the other hand came in at Rs 8 bn (down 34.7% YoY). Read on for a complete analysis of BIOCON 's quarterly results.

DR. REDDYS LAB Announces Quarterly Results (3QFY19); Net Profit Up 67.0% (Quarterly Result Update)

Feb 4, 2019 | Updated on Feb 4, 2019

For the quarter ended December 2018, DR. REDDYS LAB has posted a net profit of Rs 5 bn (up 67.0% YoY). Sales on the other hand came in at Rs 39 bn (up 0.8% YoY). Read on for a complete analysis of DR. REDDYS LAB's quarterly results.

BIOCON LTD Announces Quarterly Results (3QFY19); Net Profit Up 169.2% (Quarterly Result Update)

Jan 28, 2019 | Updated on Jan 28, 2019

For the quarter ended December 2018, BIOCON LTD has posted a net profit of Rs 2 bn (up 169.2% YoY). Sales on the other hand came in at Rs 15 bn (up 45.6% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (2QFY19); Net Profit Up 501.9% (Quarterly Result Update)

Nov 9, 2018 | Updated on Nov 9, 2018

For the quarter ended September 2018, BIOCON LTD has posted a net profit of Rs 4 bn (up 501.9% YoY). Sales on the other hand came in at Rs 13 bn (up 36.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

BIOCON LTD Announces Quarterly Results (1QFY19); Net Profit Up 47.2% (Quarterly Result Update)

Jul 30, 2018 | Updated on Jul 30, 2018

For the quarter ended June 2018, BIOCON LTD has posted a net profit of Rs 1 bn (up 47.2% YoY). Sales on the other hand came in at Rs 11 bn (up 20.4% YoY). Read on for a complete analysis of BIOCON LTD's quarterly results.

More Views on News

Most Popular

Why Super Investor Kenneth Andrade is Bullish on Agri Stocks...and So Are We(The 5 Minute Wrapup)

Jun 21, 2019

Andrade gives his take on agriculture, an industry from which we have already recommended two stocks.

Why I Believe Smallcaps Will Catch up to the Sensex(Profit Hunter)

Jun 14, 2019

Smallcaps have gone nowhere even as the Sensex makes new all-time highs. Find out why Richa believes this a good opportunity to invest in smallcaps.

This Little-Known Opportunity Promises Both Health and Wealth for Your Grandchildren(Profit Hunter)

Jun 20, 2019

The next big opportunity that has the potential to make you both rich and healthy.

My Upcoming Stock Recommendation, Backed by Aberdeen Standard Investments, Scores 9.1/10(The 5 Minute Wrapup)

Jun 19, 2019

This month's Smart Money Secrets recommendation is from global super investor - Aberdeen Standard Investments.

One Stock that Will Gain from the Electric Vehicle Disruption(The 5 Minute Wrapup)

Jun 25, 2019

Even if the share of the unorganized segment does not fall sharply, one player in the duopolistic battery sector has a lot to gain.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2019
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

BIOCON SHARE PRICE


Jun 27, 2019 11:45 AM

TRACK BIOCON

COMPARE BIOCON WITH

MARKET STATS